Payton Pritchard scores 24 points, Celtics roll past Ja Morant-less Grizzlies 131-95

BOSTON (AP) — Payton Pritchard hit five 3-pointers, scored 24 points and had nine assists and the Boston Celtics used a big second half to run past the Memphis Grizzlies 131-95 on Wednesday night.

The Grizzlies played without Ja Morant, the star guard who sat out because of a right ankle injury sustained Tuesday night in a loss at New York.

Derrick White added 20 points for Boston, and Jaylen Brown had 19.

The Celtics never trailed, made 21 3-pointers and led by 38 points. They also pushed the Grizzlies around inside, outrebounding them 58-41 and holding a 34-12 edge in second-chance points.

Jaren Jackson Jr. had 18 points for Memphis, which lost for the seventh time in eight games. Santi Aldama finished with 14 points.

Morant had appeared in five straight games following a one-game suspension Nov. 2 at Toronto for what the Grizzlies said was conduct detrimental to the team.

Without its star, Memphis struggled to keep pace with Boston’s offensive output, shooting 34% (32 of 95) from the field and 10 of 43 from the 3-point line.

A night after shooting under 28%in the first half of their loss at Philadelphia on Tuesday the Celtics found their range at home, connecting on 53% (27 of 51) of their shots in opening 24 minutes to take a 67-46 lead.

Grizzlies: At Cavaliers on Saturday.

Celtics: Host Clippers on Sunday.

AP NBA: https://apnews.com/hub/NBA

Boston Celtics guard Jordan Walsh (27) drives to the basket against Memphis Grizzlies center Jock Landale (31) during the first half of an NBA basketball game, Wednesday, Nov. 12, 2025, in Boston. (AP Photo/Charles Krupa)

Memphis Grizzlies forward Santi Aldama (7) looks to pass while covered by Boston Celtics forward Josh Minott (8) during the first half of an NBA basketball game, Wednesday, Nov. 12, 2025, in Boston. (AP Photo/Charles Krupa)

Boston Celtics guard Anfernee Simons, left, takes a 3-point shot against Memphis Grizzlies guard Cedric Coward (23) during the first half of an NBA basketball game, Wednesday, Nov. 12, 2025, in Boston. (AP Photo/Charles Krupa)

Boston Celtics guard Derrick White, right, passes the ball while pressured by Memphis Grizzlies forward Santi Aldama (7) during the first half of an NBA basketball game, Wednesday, Nov. 12, 2025, in Boston. (AP Photo/Charles Krupa)

Boston Celtics center Neemias Queta (88) and guard Jordan Walsh (27) block a shot by Memphis Grizzlies forward Jaren Jackson Jr. during the first half of an NBA basketball game, Wednesday, Nov. 12, 2025, in Boston. (AP Photo/Charles Krupa)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.